Structure of AM580
CAS No.: 102121-60-8
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
AM580 is the stable retinobenzoic derivative that acts as an agonist of RARα.
Synonyms: CD336; Ro 40-6055; NSC608001
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 102121-60-8 |
Formula : | C22H25NO3 |
M.W : | 351.44 |
SMILES Code : | O=C(O)C1=CC=C(NC(C2=CC=C3C(C)(C)CCC(C)(C)C3=C2)=O)C=C1 |
Synonyms : |
CD336; Ro 40-6055; NSC608001
|
MDL No. : | MFCD00673916 |
InChI Key : | SZWKGOZKRMMLAJ-UHFFFAOYSA-N |
Pubchem ID : | 2126 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H315-H319-H335 |
Precautionary Statements: | P261-P305+P351+P338 |
In Vitro:
Cell Line
|
Concentration | Treated Time | Description | References |
Primary microglia | 100 μM | 12 hours | Am580 markedly attenuated TLR agonists-induced iNOS expression, without canceling their basic immune response. | PMC8740456 |
MMTV-wnt1 cells | 50 nM | 13 days | AM580 treatment increased caspase-3 expression in all of the colonies, and in 30% of the colonies induced acinar-like cavitation | PMC2891995 |
HEp-2 cells | 20 µM | 24 hours | AM580 significantly inhibited AdV5 replication in HEp-2 cells | PMC6328544 |
RD cells | 20 µM | 24 hours | AM580 significantly inhibited EV-A71 replication in RD cells | PMC6328544 |
THP-1 cells | 20 µM | 24 hours | AM580 significantly inhibited MERS-CoV replication in THP-1 cells | PMC6328544 |
Vero cells | 20 µM | 24 hours | AM580 significantly inhibited MERS-CoV replication in Vero cells | PMC6328544 |
A549 cells | 20 µM | 24 hours | AM580 significantly inhibited MERS-CoV replication in A549 cells | PMC6328544 |
Calu-3 cells | 20 µM | 24 hours | AM580 significantly inhibited MERS-CoV replication in Calu-3 cells | PMC6328544 |
Huh7 cells | 20 µM | 24 hours | AM580 significantly reduced MERS-CoV replication, viral titers decreased by >3-log10 | PMC6328544 |
ACE2-HeLa cells | 20 μM | 24 hours | AM580 significantly inhibited SARS-CoV-2 replication in ACE2-HeLa cells. | PMC8449311 |
Vero-E6 cells | 20 μM | 24 hours | AM580 significantly inhibited SARS-CoV-2 replication in Vero-E6 cells. | PMC8449311 |
Huh7 cells | 20 μM | 24 hours | AM580 treatment significantly inhibited SARS-CoV-2 replication, as demonstrated by a decrease in viral protein expression and viral RNA copies. | PMC8449311 |
MCF-7 cells | 500 nM | 24 hours | To evaluate the activation effect of AM580 on the RARβ promoter, results showed that AM580 significantly increased the activity of the RARβ promoter. | PMC8997856 |
MDA-MB-231 cells | 500 nM | 24 hours | To evaluate the activation effect of AM580 on the RARβ promoter, results showed that AM580 significantly increased the activity of the RARβ promoter. | PMC8997856 |
H-4-II-E rat hepatoma cells | 1 nM to 1 µM | 24 hours | To evaluate the effect of AM580 on CYP2C22 mRNA expression, results showed that AM580 significantly upregulated CYP2C22 mRNA levels. | PMC2882718 |
Swan71 cells | 200 nM | 24 to 72 hours | To investigate the induction of RARRES1 expression by AM580 in Swan71 cells. Results showed that AM580 significantly induced RARRES1 expression. | PMC5701501 |
BeWo cells | 200 nM | 24 to 72 hours | To investigate the induction of RARRES1 expression by AM580 in BeWo cells. Results showed that AM580 alone did not significantly induce RARRES1 expression, but after pretreatment with 5-aza-2′-deoxycytidine, AM580 significantly increased RARRES1 expression. | PMC5701501 |
JAR cells | 200 nM | 24 to 72 hours | To investigate the induction of RARRES1 expression by AM580 in JAR cells. Results showed that AM580 alone did not significantly induce RARRES1 expression, but after pretreatment with 5-aza-2′-deoxycytidine, AM580 significantly increased RARRES1 expression. | PMC5701501 |
Jeg-3 cells | 200 nM | 24 to 72 hours | To investigate the induction of RARRES1 expression by AM580 in Jeg-3 cells. Results showed that AM580 alone did not significantly induce RARRES1 expression, but after pretreatment with 5-aza-2′-deoxycytidine, AM580 significantly increased RARRES1 expression. | PMC5701501 |
MDCK cells | 20 µM | 48 hours | AM580 significantly inhibited H1N1 virus replication in MDCK cells | PMC6328544 |
Primary trophoblasts | 200 nM | 48 hours | To investigate the induction of RARRES1 expression by AM580 in primary trophoblasts. Results showed that AM580 significantly induced RARRES1 expression. | PMC5701501 |
Mouse mammary epithelial cells | 200 nM | 48 hours | To evaluate the effect of Am580 on CRBP1 expression, results showed that Am580 significantly induced CRBP1 protein expression | PMC3680916 |
MDA-MB-231 cells | 200 nM | 48 hours | Increased RBP1 expression and atRA production | PMC8909206 |
MCF-7 cells | 200 nM | 48 hours | Increased RBP1 expression and atRA production | PMC8909206 |
Monocyte-derived dendritic cells (moDCs) | 100 nM | 6 days | AM580 significantly enhanced the expression levels of ANKRD55 and upregulated IL31RA expression. | PMC8801523 |
HEK293T cells | 1 µM | 6 hours | To assess the metabolic capacity of CYP2C22 for RA, results showed that CYP2C22 converted RA to polar metabolites. | PMC2882718 |
Human MCF-7 cells | 200 nM | 96 hours | To evaluate the effect of Am580 on cell proliferation, results showed that Am580 inhibited cell proliferation | PMC3680916 |
Human MCF-10A cells | 200 nM | 96 hours | To evaluate the effect of Am580 on cell proliferation, results showed that Am580 inhibited cell proliferation | PMC3680916 |
Mouse dorsal root ganglia neurons | 5 μM | AM580 activated TRPV1-mediated currents and calcium influx | PMC3754244 | |
HEK293T cells | 100 μM | AM580 activated TRPV1-mediated calcium influx | PMC3754244 |
In Vivo:
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
Zebrafish (Danio rerio) | Zebrafish embryos | Water exposure | 0.001–0.03 µM | 0–120 hpf (hours post-fertilization) | To evaluate the effect of AM580 on head skeleton malformations in zebrafish embryos. AM580 significantly increased the Meckel's–palatoquadrate (M–PQ) angle, indicating an effect on head skeleton development. | PMC6290702 |
Mice | Tg26 mice (HIV-1 transgenic mice) | Oral | 0.3 mg/kg/day | Daily from the age of 4 weeks to 12 weeks | AM580 attenuated proteinuria, glomerulosclerosis, and podocyte proliferation, and restored podocyte differentiation markers | PMC3050085 |
Mice | MMTV-Myc transgenic mouse model | Oral | 0.3 mg/kg/day | Daily administration for 50 weeks | To evaluate the effect of Am580 on mammary tumor growth and metastasis, results showed that Am580 significantly inhibited tumor growth and lung metastasis | PMC3680916 |
Mice | MMTV-neu and MMTV-wnt1 transgenic mice | Dietary addition | 0.3mg/kg/day | Daily, for 40 weeks (neu) and 35 weeks (wnt1) | AM580 treatment significantly increased tumor-free survival, reduced tumor incidence and growth of established tumors, and inhibited epithelial hyperplasia | PMC2891995 |
HIV-1 transgenic mice | Rapidly progressive renal failure model | Mixed in the animal chow | 0.3mg/kg/day | Daily for a total of 5 weeks | AM580 significantly reduced proteinuria, attenuated kidney injury, and improved podocyte differentiation. The renal protective effects were further enhanced when combined with the PDE4 inhibitor roflumilast. | PMC3326224 |
C57BL/6 mice | Experimental autoimmune encephalomyelitis (EAE) | Intraperitoneal injection | 1 mg/kg or 2 mg/kg | Administered every other day, starting on day 11 post immunization until day 21 p.i. | AM580 was ineffective in suppressing EAE development and had no significant effect on demyelination and leukocyte infiltration | PMC6804666 |
Zucker diabetic fatty rats | Diabetic cardiomyopathy model | Oral gavage | 1 mg/kg/day | Daily for 16 weeks | Am580 attenuated diabetes-induced cardiac dysfunction and the pathological alterations, by improving glucose tolerance and insulin resistance; facilitating Akt activation and glucose utilization, and attenuating oxidative stress and interrelated MAP kinase and NF-κB signaling pathways. | PMC3594065 |
Mice | Trpv1+/+ and Trpv1−/− mice | Intraplantar injection | 100 nmol/20 μl | Single injection, observed for 2 hours | AM580 induced paw edema and nociceptive behaviors via TRPV1 | PMC3754244 |
HDPP4 transgenic mice | MERS-CoV infection model | Intraperitoneal injection | 12.5 mg/kg/day | Once daily for 3 days | AM580 significantly improved the survival rate of MERS-CoV-infected mice, reduced body weight loss and lung viral load | PMC6328544 |
5xFAD transgenic mice | Alzheimer's disease model | Intracerebroventricular delivery | 28.5 mM | Continuous for 7 or 28 days | Intracerebroventricular delivery of Am580 in 5xFAD mice reduced significantly the fraction of (neurotoxic) iNOS + microglia and increased the fraction of (neuroprotective) TREM2 + microglia. Furthermore, intracerebroventricular delivery of Am580 prevented neurodegeneration induced by microbial TLR agonists. | PMC8740456 |
Rats | Vitamin A-deficient rats | Oral | 30 µg AM580 | Single dose, euthanized after 6 hours | To evaluate the effect of AM580 on CYP2C22 mRNA expression, results showed that AM580 significantly increased CYP2C22 mRNA levels. | PMC2882718 |
Tags: AM580 | CD336 | NSC608001 | Ro 40-6055 | RAR/RXR | Retinoic acid receptors | Retinoid X receptors | cell therapy manufacture | MEF | CiPSC | SH-SY5Y | neuron | promyelocytic leukemia | myeloid progenitor | neutrophil | 102121-60-8
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL